loadpatents
name:-0.020274877548218
name:-0.014364004135132
name:-0.00088810920715332
Shechter; Yoram Patent Filings

Shechter; Yoram

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shechter; Yoram.The latest application filed is for "blood-brain barrier disrupting agents and uses thereof".

Company Profile
0.12.17
  • Shechter; Yoram - Rehovot IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Reversible pegylated drugs
Grant 9,956,295 - Shechter , et al. May 1, 2
2018-05-01
Blood-brain Barrier Disrupting Agents And Uses Thereof
App 20170247429 - Cooper; Itzik ;   et al.
2017-08-31
Reversible Pegylated Drugs
App 20160324975 - SHECHTER; Yoram ;   et al.
2016-11-10
Albumin binding probes and drug conjugates thereof
Grant 9,480,751 - Shechter , et al. November 1, 2
2016-11-01
Reversible pegylated drugs
Grant 9,433,683 - Shechter , et al. September 6, 2
2016-09-06
Reversible Pegylated Drugs
App 20160000927 - SHECHTER; Yoram ;   et al.
2016-01-07
Reversible pegylated drugs
Grant 9,119,883 - Shechter , et al. September 1, 2
2015-09-01
Albumin Binding Probes And Drug Conjugates Thereof
App 20150202310 - Shechter; Yoram ;   et al.
2015-07-23
Prodrugs Containing Albumin Binding Probe
App 20150093370 - SHECHTER; Yoram ;   et al.
2015-04-02
Reversible Pegylated Drugs
App 20150057219 - SHECHTER; Yoram ;   et al.
2015-02-26
Reversible pegylated drugs
Grant 8,877,709 - Shechter , et al. November 4, 2
2014-11-04
Reversible pegylated drugs
Grant 8,735,350 - Shechter , et al. May 27, 2
2014-05-27
Reversible Pegylated Drugs
App 20140121352 - SHECHTER; YORAM ;   et al.
2014-05-01
Reversible Pegylated Drugs
App 20130116175 - SHECHTER; Yoram ;   et al.
2013-05-09
Reversible pegylated drugs
Grant 8,343,910 - Shechter , et al. January 1, 2
2013-01-01
Prodrugs Containing Albumin Binding Probe
App 20120134977 - Shechter; Yoram ;   et al.
2012-05-31
Reversible Pegylated Drugs
App 20100041867 - SHECHTER; Yoram ;   et al.
2010-02-18
Reversible pegylated drugs
Grant 7,585,837 - Shechter , et al. September 8, 2
2009-09-08
Long-acting derivatives of pyy agonists
App 20070027073 - Rubinstein; Menachem ;   et al.
2007-02-01
Reversible pegylated drugs
App 20060171920 - Shechter; Yoram ;   et al.
2006-08-03
Oral absorbed drugs
App 20050004000 - Shechter, Yoram ;   et al.
2005-01-06
Long-acting cytokine derivatives and pharmaceutical compositions comprising them
App 20040131586 - Shechter, Yoram ;   et al.
2004-07-08
Long-acting exendins and exendin agonists
App 20040092443 - Fridkin, Matityahu ;   et al.
2004-05-13
Long-acting drugs and pharmaceutical compositions comprising them
Grant 6,504,005 - Fridkin , et al. January 7, 2
2003-01-07
Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
Grant 6,414,029 - Shechter , et al. July 2, 2
2002-07-02
Tryptophan derivatives as protein tyrosine kinase blockers and their use in the treatment of neoplastic diseases
Grant 5,776,970 - Shechter , et al. July 7, 1
1998-07-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed